[1] 孙浩, 曹丽, 曹林, 等. 腹腔镜肝切除术治疗原发性肝癌患者应用氢吗啡酮联合纳布啡静脉自控镇痛控制疼痛作用研究. 实用肝脏病杂志, 2022, 25(3):415-418. [2] Jan J, Osho A, Murphy CC, et al. Gender,age, racial and ethnic disparities in clinical trial enrollment for primary liver cancer. Gastroenterology, 2022, 163(1):14-20. [3] Li X, Ramadori P, Pfister D, et al. The immunological and metabolic landscape in primary and metastatic liver cancer. Nat Rev Cancer, 2021, 21(9):541-557. [4] 樊顺克, 王贵罗, 伊晓燕. 七氟醚联合丙泊酚静-吸复合麻醉用于原发性肝癌根治术治疗经验介绍. 实用肝脏病杂志, 2022, 25(5):702-705. [5] Huang X, Chen Y, Shi X. Laparoscopic hepatectomy versus open hepatectomy for tumors located in right posterior segment: A single institution study. Asian J Surg, 2022, 45(1):110-116. [6] Felli E, Muttillo EM, Felli E. Interpatient heterogeneity in hepatic microvascular blood flow during vascular inflow occlusion (pringle manoeuvre). Hepatobiliary Surg Nutr, 2021, 10(3):413-415. [7] Choi YI. The usefulness of the totally intra-corporeal pringle maneuver withpenrose drain tube during laparoscopic left side liver resection. Ann Hepatobiliary Pancreat Surg, 2020, 24(3):252-258. [8] Zhang Y, Lu X, Xu J, et al. Intermittent Pringleversus continuous half-pringle maneuver for laparoscopic liver resections of tumors in segment 7. Indian J Surg, 2018, 80(2):146-153. [9] 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗指南(2022年版). 中华肝脏病杂志, 2022, 30(4):367-388. [10] Sharma R. Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018. Jpn J Clin Oncol, 2020, 50(12):1370-1379. [11] Liu Z, Suo C, Mao X, et al. Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990-2017. Cancer, 2020, 126(10):2267-2278. [12] Liu Z, Xu K, Jiang Y, et al. Global trend of aetiology-based primary liver cancer incidence from 1990 to 2030: a modelling study. Int J Epidemiol, 2021, 50(1):128-142. [13] Ji Q, Fu Y, Zhu X, et al. Effect of RFA and TACE combined with postoperative cytokine-induced killer cell immunotherapy in primary hepatocellular carcinoma. J BUON, 2021, 26(1):235-242. [14] Duong LM, Cai H, Shrubsole MJ, et al. Outcomes of robotic-assisted liver surgery versus laparoscopic liver surgery for treatment of stage I hepatocellular carcinoma. Cancer, 2022, 128(4):762-769. [15] Hong SK, Choi GS, Han J, et al. Pure laparoscopic donor hepatectomy: a multicenter experience. Liver Transpl, 2021, 27(1):67-76. [16] Cao P, Rozek LS, Pongnikorn D, et al. Comparison of cholangiocarcinoma and hepatocellular carcinoma incidence trends from 1993 to 2012 in Lampang, Thailand. Int J Environ Res Public Health, 2022, 19(15):9551. [17] Zhang C, Yu J, Ma J. How to perform laparoscopic intracorporeal pringle manoeuvre: zhang's modified method. ANZ J Surg, 2021, 91(4):742-743. [18] Hu Q, Xia X. Safety and effectiveness of hemihepatic blood flow occlusion versus Pringle's maneuver during hepatectomy: a meta-analysis. Asian J Surg, 2021, 44(9):1226. [19] 舒强, 刘小玲, 徐波. Glisson蒂横断法与Pringle法在肝细胞癌肝切除术中的应用效果Meta分析. 中国普通外科杂志, 2022, 31(1):42-54. [20] Gao Z, Li Z, Zhou B, et al. A self-designed liver circle for on-demand Pringle's manoeuver in laparoscopic liver resection. J Minim Access Surg, 2021, 17(1):120-126. [21] Al-Saeedi M, Ghamarnejad O, Khajeh E, et al. Pringle maneuver in extended liver resection: a propensity score analysis. Sci Rep, 2020, 10(1):8847. [22] Pavlidis ET, Pavlidis TE. Pathophysiological consequences of obstructive jaundice and perioperative management. Hepatobiliary Pancreat Dis Int, 2018, 17(1):17-21. [23] Yoshida H, Taniai N, Yoshioka M, et al. Current status of laparoscopic hepatectomy. J Nippon Med Sch, 2019, 86(4):201-206. |